BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27428748)

  • 1. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.
    Zhang X; Su J; Jeong M; Ko M; Huang Y; Park HJ; Guzman A; Lei Y; Huang YH; Rao A; Li W; Goodell MA
    Nat Genet; 2016 Sep; 48(9):1014-23. PubMed ID: 27428748
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kunimoto H; McKenney AS; Meydan C; Shank K; Nazir A; Rapaport F; Durham B; Garrett-Bakelman FE; Pronier E; Shih AH; Melnick A; Chaudhuri J; Levine RL
    Blood; 2017 Mar; 129(13):1779-1790. PubMed ID: 28077417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
    Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
    Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
    Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
    Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
    Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
    Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking hematopoietic precursor division ex vivo in real time.
    Wang Y; Tian H; Cai W; Lian Z; Bhavanasi D; Wu C; Sato T; Kurokawa M; Wu D; Fu L; Wang H; Shen H; Liang D; Huang J
    Stem Cell Res Ther; 2018 Jan; 9(1):16. PubMed ID: 29361987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
    Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
    Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dnmt3a is essential for hematopoietic stem cell differentiation.
    Challen GA; Sun D; Jeong M; Luo M; Jelinek J; Berg JS; Bock C; Vasanthakumar A; Gu H; Xi Y; Liang S; Lu Y; Darlington GJ; Meissner A; Issa JP; Godley LA; Li W; Goodell MA
    Nat Genet; 2011 Dec; 44(1):23-31. PubMed ID: 22138693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.
    López-Moyado IF; Tsagaratou A; Yuita H; Seo H; Delatte B; Heinz S; Benner C; Rao A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16933-16942. PubMed ID: 31371502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lineage restriction analyses in CHIP indicate myeloid bias for
    Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
    Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
    Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
    Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a.
    Hu W; Dooley J; Chung SS; Chandramohan D; Cimmino L; Mukherjee S; Mason CE; de Strooper B; Liston A; Park CY
    Blood; 2015 Apr; 125(14):2206-16. PubMed ID: 25634742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
    Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
    Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
    Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis.
    Zhang X; Wang X; Wang XQD; Su J; Putluri N; Zhou T; Qu Y; Jeong M; Guzman A; Rosas C; Huang Y; Sreekumar A; Li W; Goodell MA
    Blood; 2020 Mar; 135(11):845-856. PubMed ID: 31932841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.
    Palam LR; Mali RS; Ramdas B; Srivatsan SN; Visconte V; Tiu RV; Vanhaesebroeck B; Roers A; Gerbaulet A; Xu M; Janga SC; Takemoto CM; Paczesny S; Kapur R
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation.
    Koya J; Kataoka K; Sato T; Bando M; Kato Y; Tsuruta-Kishino T; Kobayashi H; Narukawa K; Miyoshi H; Shirahige K; Kurokawa M
    Nat Commun; 2016 Mar; 7():10924. PubMed ID: 27010239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.